SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent provider and producer of hemp cannabidiol (CBD) merchandise, at present introduced that it’s going to launch monetary outcomes for the primary quarter ended March 31, 2021, after the inventory market closes on Thursday, May 13, 2021. The Company will maintain a convention name with the funding group at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that very same day.
The webcast of the convention name will probably be out there on the Investor Relations part of the Company’s web site at https://ir.cvsciences.com/news-events and at http://public.viavid.com/index.php?id=144697 . The webcast will probably be archived for about 30 days. Investors concerned about collaborating within the dwell name may dial (877) 407-0784 from the U.S. or worldwide callers can dial (201) 689-8560. Please dial the convention phone quantity quarter-hour previous to the beginning time as a consequence of elevated demand for convention calls.
A phone replay will probably be out there roughly two hours after the decision concludes and will probably be out there by means of Thursday, May 20, 2021, by dialing (844) 512-2921 from the U.S. or (412) 317-6671 from worldwide places, and coming into affirmation code 13719303.
About CV Sciences, Inc.
CV, or Curriculum Vitae, is Latin for “course of life”, and science is the pursuit of reality. CV Sciences: our identify is our mission -improving high quality of life by means of nature and science.
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct enterprise segments: a client product division targeted on manufacturing, advertising and promoting plant-based dietary dietary supplements and CBD merchandise to a variety of market sectors; and a drug growth division targeted on growing and commercializing CBD-based novel therapeutics. The Company’s PlusCBD™ merchandise are offered at greater than 7,300 retail places all through the U.S. and it’s the top-selling model of hemp-derived CBD within the pure merchandise market, in accordance with SPINS, the main supplier of syndicated knowledge and insights for the pure, natural and specialty merchandise business. CV Sciences follows all tips for Good Manufacturing Practices (GMP) and the Company’s merchandise are processed, produced, and examined all through the manufacturing course of to verify strict compliance with firm requirements and specs. With a dedication to science, PlusCBD™ product advantages in wholesome individuals are supported by human scientific analysis knowledge, along with three revealed scientific case research out there on PubMed.gov. PlusCBD™ was the primary hemp CBD complement model to spend money on the scientific proof essential to obtain self-affirmed Generally Recognized as Safe (GRAS) standing. CV Sciences, Inc. has major workplaces and amenities in San Diego, California. Additional info is offered from OTCMarkets.com or by visiting www.cvsciences.com.
This press launch could comprise sure forward-looking statements and knowledge, as outlined inside the which means of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is topic to the Safe Harbor created by these sections. This materials comprises statements about anticipated future occasions and/or monetary outcomes which can be ahead wanting in nature and topic to dangers and uncertainties. Such forward-looking statements by definition contain danger and uncertainties.